In FAD models and AD human postmortem tissue, GFAP immunostaining is higher than wild-type or age-matched controls, respectively, particularly surrounding Aβ extracellular deposits and neurofibrillary tangles of tau (Simpson et al., 2010; Verkhratsky et al., 2010). The gene discussed is MAPT; the disease is Alzheimer disease.